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-Catenin is essential for E-cadherin–mediated cell
adhesion in epithelial cells, but it also forms nuclear
complexes with high mobility group transcription
 
factors. Using a mouse mammary epithelial cell sys-
tem, we have shown previously that conversion of epithelial
cells to a ﬁbroblastoid phenotype (epithelial-mesenchymal
transition) involves downregulation of E-cadherin and
 
upregulation of 
 
 
 
-catenin transcriptional activity. Here,
we demonstrate that transient expression of exogenous
 
E-cadherin in both epithelial and ﬁbroblastoid cells arrested
cell growth or caused apoptosis, depending on the cellular
E-cadherin levels. By expressing E-cadherin subdomains,
we show that the growth-suppressive effect of E-cadherin
required the presence of its cytoplasmic 
 
 
 
-catenin interac-
 
 
tion domain and/or correlated strictly with the ability to
 
negatively interfere with 
 
 
 
-catenin transcriptional activ-
ity. Furthermore, coexpression of 
 
 
 
-catenin or lymphoid
enhancer binding factor-1 or T cell factor 3 with E-cadherin
rescued 
 
 
 
-catenin transcriptional activity and counteracted
E-cadherin–mediated cell cycle arrest. Stable expression
 
of E-cadherin in ﬁbroblastoid cells decreased 
 
 
 
-catenin
activity and reduced cell growth. Since proliferating cells
 
had a higher 
 
 
 
-catenin activity than G1 phase–arrested
or contact-inhibited cells, we conclude that 
 
 
 
-catenin
 
transcriptional activity is essential for cell proliferation
and can be controlled by E-cadherin in a cell adhesion-
independent manner.
 
Introduction
 
Cadherins represent a distinct family of single transmem-
brane domain glycoproteins that mediate calcium-dependent
cell–cell adhesion via homophilic interactions of their NH
 
2
 
-
terminal ectodomains (Shapiro et al., 1995; Gumbiner,
2000). The intracellular domain of E-cadherin associates
with a protein family collectively termed catenins (Ozawa et
al., 1989; Nathke et al., 1994). 
 
 
 
-catenin and 
 
 
 
-catenin
(plakoglobin) interact directly with E-cadherin’s COOH-
terminal domain in a mutually exclusive way, and both pro-
teins associate with 
 
 
 
-catenin, which links the cadherin
complexes to the actin cytoskeleton and mediates stable cell
adhesion. p120ctn is another catenin family member (Anas-
 
tasiadis and Reynolds, 2000), which binds to the cytoplas-
mic juxtamembrane portion of E-cadherin and influences
E-cadherin clustering and adhesive strength (Ozawa and
Kemler, 1998; Yap et al., 1998; Aono et al., 1999; Ohkubo
and Ozawa, 1999; Thoreson et al., 2000).
 
In addition to its adhesive functions, 
 
 
 
-catenin has also
been found to serve as a key component in signaling pro-
cesses during embryonic development and adult tissue
homeostasis. A series of genetic and biochemical studies have
identified 
 
 
 
-catenin as a central player of the wnt/wingless
signal transduction cascade, which is important for pattern
formation and axis determination during early development
of invertebrate and vertebrate organisms (Kelly et al., 1995;
Cox et al., 1996; Willert and Nusse, 1998; Huelsken et al.,
2000). In the absence of wnt ligand, cytoplasmic 
 
 
 
-catenin
is part of a supramolecular complex containing axin/conduc-
tin and the adenomatous polyposis coli tumor suppressor
protein and is NH
 
2
 
-terminally phosphorylated by glycogen
 
synthase kinase 3
 
 
 
 (Rubinfeld et al., 1996; Yost et al.,
1996; Behrens et al., 1998; Ikeda et al., 1998), which tar-
gets the protein for proteosomal degradation (Aberle et al.,
1997; Orford et al., 1997). The binding of wnt to its cog-
nate receptor frizzled triggers a cascade of signaling events
that led to the inhibition of glycogen synthase kinase 3
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dependent phosphorylation of 
 
 
 
-catenin. Stabilized hypo-
phosphorylated 
 
 
 
-catenin accumulates in the cytoplasm
and the nucleus and interacts with high mobility group
box containing transcription factors of the lymphoid en-
hancer binding factor (LEF)*-1/T cell factor (TCF) family
(Behrens et al., 1996; Huber et al., 1996; Molenaar et al.,
1996). The nuclear 
 
 
 
-catenin–LEF/TCF complex can
transactivate transcription by binding to coactivators,
such as histone acetylase p300/CBP (Hecht et al., 2000;
Sun et al., 2000; Takemaru and Moon, 2000) and the
TATA-binding protein TBP (Hecht et al., 1999), or can
repress transcription by interaction with repressors such as
groucho-related gene 5 (Roose et al., 1998). Both transac-
tivation and repressive functions of the 
 
 
 
-catenin–LEF/
TCF complex are highly regulated and control the expres-
sion of a diverse set of target genes during development
and tissue formation in invertebrates and vertebrates (for
reviews see Roose and Clevers, 1999; Hecht and Kemler,
2000; Zhurinsky et al., 2000b).
Inappropriate activation of the wnt pathway was shown to
drive cell proliferation and tumor formation (Korinek et al.,
1997; Morin et al., 1997; Rubinfeld et al., 1997; for reviews
see Barker and Clevers, 2000; Bienz and Clevers, 2000; Po-
lakis, 2000). Increased 
 
 
 
-catenin transcriptional activity
upon overexpression of stable activated 
 
 
 
-catenin in the in-
testine (Harada et al., 1999) or of truncated 
 
 
 
-catenin in the
skin (Gat et al., 1998) of transgenic mice led to the develop-
ment of intestinal polyps and hair tumors, respectively.
In addition, the development of invasive tumors from epi-
thelial tissues frequently involves the conversion of epithelial
cells to a mesenchymal fibroblastoid phenotype (epithelial-
mesenchymal transition [EMT]), which is characterized by
downregulation of E-cadherin (Birchmeier et al., 1996;
Christofori and Semb, 1999). In line with this hypothesis,
ectopic expression of E-cadherin in a transgenic mouse
model of pancreatic 
 
 
 
-cell carcinogenesis arrested tumor de-
velopment (Perl et al., 1998), and E-cadherin expression in
mammary carcinoma cells was found to inhibit cell growth
(St. Croix et al., 1998). We have found recently that EMT
was also accompanied by an upregulation of 
 
 
 
-catenin/
LEF-1 activity (Eger et al., 2000). Since E-cadherin is
known to negatively regulate 
 
 
 
-catenin transcriptional activ-
ity by recruiting 
 
 
 
-catenin from transcriptional complexes
(Heasman et al., 1994; Fagotto et al., 1996; Sadot et al.,
1998; Simcha et al., 1998; Orsulic et al., 1999; Eger et al.,
2000), cellular E-cadherin levels might regulate LEF-1/TCF
activity and thus be crucial for regulating cell proliferation
and neoplastic transformation. However, a direct relation-
ship between E-cadherin expression and 
 
 
 
-catenin signaling
in the control of cell proliferation has not been demon-
strated yet.
Mouse mammary epithelial cells expressing an estrogen-
inducible cFos estrogen receptor fusion protein (FosER) are
epithelial and express E-cadherin but upon estrogen treat-
ment convert to fibroblastoid cells that are devoid of E-cad-
herin (Reichmann et al., 1992). Using FosER cells before
and after estradiol-induced EMT (Eger et al., 2000), we
show here that ectopic expression of E-cadherin in both epi-
thelial and fibroblastoid cells resulted in retardation of cell
growth and G1 phase arrest, depending on the expression
level of exogenous E-cadherin. Expression of E-cadherin
subdomains revealed that the growth suppressive effect is
cell adhesion-independent and strictly correlated with the
downregulation of 
 
 
 
-catenin/LEF activity.
 
Results
 
Ectopic expression of E-cadherin blocks cell cycle 
progression in epithelial and fibroblastoid cells
 
To test the relationship between E-cadherin expression and
 
 
 
-catenin/LEF signaling during cell cycle progression, we
used the FosER cell system (Reichmann et al., 1992) for two
reasons. First, the cellular phenotype is controlled by estra-
diol-dependent activity of a constitutively expressed cFos–
estrogen receptor chimeric protooncogene. Whereas cells
form highly polarized epithelial cell sheets in the absence of
estradiol, estradiol-induced activation of FosER induces
EMT, leading to fibroblastoid cells that lack E-cadherin and
exhibit increased 
 
 
 
-catenin/LEF-1 transcriptional activity
(Eger et al., 2000). This allowed us to analyze the effects of
ectopic E-cadherin expression on cell proliferation in two
different cellular phenotypes of a single cell clone, expressing
or lacking endogenous E-cadherin. Second, we have shown
previously that transient expression of E-cadherin in fibro-
blastoid and epithelial FosER cells significantly reduced
 
 
 
-catenin/LEF transcriptional activity (Eger et al., 2000).
 
*Abbreviations used in this paper: EMT, epithelial-mesenchymal transi-
tion; FosER, cFos estrogen receptor fusion protein; LEF, lymphoid en-
hancer binding factor; TCF, T cell factor.
Figure 1. Transient expression of ectopic E-cadherin. 
Epithelial and fibroblastoid FosER cells were trans-
fected with an expression plasmid encoding full-
length myc-tagged E-cadherin and processed for 
double immunofluorescence microscopy 24 h after 
transfection using antibodies to the myc tag (A–D) and 
 -catenin (A –D ). Confocal images are shown.
Bar, 10  m. 
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Upon transient expression of myc- or GFP-tagged full-
length E-cadherin in epithelial FosER cells, we observed
two major phenotypes. Cells expressing exogenous E-cad-
herin at a very low level revealed a nearly exclusive localiza-
tion of the tagged protein at the lateral plasma membrane
(Fig. 1 A), similar to the localization of the endogenous
E-cadherin. Higher expression levels led to an additional
cytoplasmic localization of the ectopic E-cadherin, pre-
sumably representing E-cadherin localized in the ER, the
Golgi, or in vesicles on their way to the plasma membrane
(Fig. 1 B; Adams et al., 1998). Ectopically expressed E-cad-
herin colocalized with endogenous 
 
 
 
-catenin at the plasma
membrane, suggesting that it is incorporated into func-
tional cell–cell adhesion complexes (Fig. 1 A
 
 
 
), but high
levels of ectopic E-cadherin led to cytoplasmic accumula-
tion of endogenous 
 
 
 
-catenin most likely due to the for-
mation of cytoplasmic E-cadherin–
 
 
 
-catenin complexes
(Fig. 1 B
 
 
 
). In fibroblastoid FosER cells, expression of ex-
ogenous E-cadherin at moderate levels resulted in its pre-
dominantly peripheral localization at the plasma mem-
brane and a partial recruitment of 
 
 
 
-catenin to the cellular
periphery (Fig. 1 C). Higher expression levels resulted in
increased cytoplasmic E-cadherin and a strong upregula-
tion of endogenous 
 
 
 
-catenin levels in the cytoplasm (Fig.
1 D). In agreement with previous studies (Gottardi et al.,
2001) showing that E-cadherin expression in colon cancer
cells did not change 
 
 
 
-catenin’s nuclear localization, al-
though it interfered with 
 
 
 
-catenin transcriptional activity,
we did not observe a clear depletion of 
 
 
 
-catenin from the
nucleus in E-cadherin–expressing cells.
 
To analyze the effect of ectopic E-cadherin expression on
cell cycle progression, we determined the percentage of
transfected cells in S phase by testing for the incorporation
of BrdU into cellular DNA. 48 h after transfection of cells
with E-cadherin constructs or with GFP vectors alone, nu-
clei of most cells expressing high levels of E-cadherin did not
stain for BrdU, whereas a large number of nuclei in non-
transfected cells in the same preparation (Fig. 2 A, top) or
in GFP-expressing control cells (unpublished data) were
stained brightly with the BrdU antibody. Statistical analysis
of these data revealed that 
 
 
 
70% of epithelial and fibroblas-
toid cells transfected with the GFP construct alone incorpo-
rated BrdU independent of GFP expression levels (Fig. 2 B).
In contrast, upon moderate expression of E-cadherin in epi-
thelial cells (defined by mostly peripheral localization of
E-cadherin; Fig. 1 A) only 20% of cells exhibited BrdU-
specific staining (Fig. 2 B, Epithelial FosER, white bar),
and almost no BrdU incorporation could be detected in epi-
thelial cells expressing high levels of the protein in the cyto-
plasm (Fig. 2 B, Epithelial FosER, black bar)
 
.
 
 In fibro-
blastoid cells, the decrease in BrdU incorporation was less
efficient than in epithelial cells, yielding a reduction of
BrdU-positive cells to 40% upon low level expression of
E-cadherin and to 
 
 
 
5% in highly expressing cells (Fig. 2 B,
Fibroblastoid FosER, white and black bars). Thus, E-cadherin
expression led to a significant reduction in DNA synthesis,
suggesting that increased cellular E-cadherin levels might
cause a growth arrest in the G1 phase of the cell cycle. To di-
rectly prove G1 phase arrest, we stained transfected cells with
an antibody to the cyclin-dependent kinase inhibitor p27
 
KIP1
 
,
Figure 2. Expression of E-cadherin leads to G1-S 
phase arrest. Epithelial and fibroblastoid FosER cells 
were transfected with expression plasmids encoding 
full-length GFP- or myc-tagged E-cadherin and 
analyzed for BrdU incorporation and/or double 
immunofluorescence microscopy 24 h after 
transfection. (A) Confocal images of cells stained with 
antibodies to myc and BrdU (top) or to myc and 
p27
KIP1 (bottom) and with the DNA dye Hoechst are 
shown. (B) Cells expressing E-cadherin–GFP or GFP 
alone as a control were analyzed for BrdU incorpora-
tion, and the percentage of BrdU-positive cells of all 
GFP-positive cells was determined by statistical 
analysis ( 500 cells). Data represent mean values of 
at least three independent experiments; SD is shown. 
White bars, weak expression; black bars, strong 
expression of E-cadherin or GFP. Bar, 10  m. 
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Figure 3. Prolonged expression of ectopic E-cadherin 
caused apoptosis. Epithelial and fibroblastoid FosER 
cells were transfected with expression plasmids 
encoding full-length GFP- or myc-tagged E-cadherin, 
GFP-cadherin and  -catenin, or GFP as control. (A) 
GFP and E-cadherin–GFP–expressing cells were 
analyzed by FACS
® within 4 d after transfection. The 
graph shows the percentage of E-cadherin–GFP–
positive cells relative to GFP-positive cells (set to 
100%) at each time point. Mean values and SD of at 
least three independent experiments are shown. (B) 
Epithelial FosER cells expressing ectopic E-cadherin 
were analyzed for apoptosis 48 h after transfection 
using the TUNEL assay and processed for immunoflu-
orescence microscopy using myc antibody to 
visualize E-cadherin. Confocal images are shown. 
Bar, 10  m.
Figure 4. Expression of E-cadherin deletion mutants in 
epithelial and fibroblastoid FosER cells. (A) Schematic 
drawing of E-cadherin deletion mutants. p120 and 
 -cat denote interaction domains of E-cadherin with 
p120ctn and  -catenin, respectively. TM, transmem-
brane domain; numbers, position of amino acid in 
processed E-cadherin (B). Fibroblastoid FosER cells 
were transfected with plasmids encoding myc-tagged 
E-cadherin fragments. Cell lysates were prepared 24 h 
after transfection and analyzed by immunoblotting 
using antibody to myc. Asterisks denote position of 
construct. Control, nontransfected cells. (C) Trans-
fected cells were processed for double immunofluo-
rescence microscopy 24 h after transfection using 
antibodies to myc and to  -catenin. Confocal images 
are shown. Bar, 10  m. 
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which has been found to be upregulated upon E-cadherin–
induced growth suppression (St. Croix et al., 1998). As shown
in Fig. 2 A (bottom), p27
 
KIP1
 
 was significantly upregulated ex-
clusively in nuclei of cells expressing high levels of E-cadherin.
 
Prolonged expression of ectopic E-cadherin leads
to apoptosis
 
To test whether ectopic E-cadherin–mediated G1 phase ar-
rest is a transient or constitutive effect and to analyze the fate
of transfected cells upon prolonged cultivation, we tran-
siently transfected epithelial and fibroblastoid FosER cells
with E-cadherin–GFP fusion constructs or GFP alone and
followed the number of transfected GFP-positive cells over
a period of 4 d after transfection by FACS
 
®
 
 analysis.
When compared with GFP-expressing cells (set to 100%),
the number of GFP–E-cadherin–positive epithelial cells
dropped dramatically to a value close to zero after 4 d (Fig. 3
A). The number of fibroblastoid cells expressing E-cad-
herin–GFP was also strongly reduced within 4 d, but as in
the BrdU incorporation experiments the reduction was less
efficient than in epithelial cells. The decrease in E-cadherin–
GFP–expressing cells during prolonged cultivation was con-
sistent with a G1 phase arrest of transfected cells, but the
dramatic downregulation within the short time period could
not be explained by growth arrest alone. Since the stability
of GFP and E-cadherin–GFP fusion proteins were similar
(unpublished data), we reasoned that G1 phase–arrested cells
might enter apoptosis. Indeed, 
 
 
 
50% of cells highly overex-
pressing E-cadherin showed plasma membrane blebbing and
nuclear fragmentation 24–48 h after transfection and were
shown by TUNEL staining to undergo apoptosis (Fig. 3 B).
After 4 d, only cells expressing low levels of E-cadherin were
detected, and 
 
 
 
10% of those were apoptotic. Thus, cell cy-
cle arrest by ectopic E-cadherin apparently resulted in cell
death upon prolonged cultivation.
 
The growth-suppressive effect of E-cadherin is 
mediated by domains affecting 
 
 
 
-catenin 
transcriptional activity and is cell
adhesion independent
 
To determine the domains of E-cadherin responsible for
growth suppression and apoptosis, we generated E-cadherin
deletion mutants, missing either the cytoplasmic juxtamem-
brane p120ctn binding domain (Ecad-
 
 
 
cat) or the COOH-
terminal 
 
 
 
-catenin binding domain (Ecad-p120), but both
constructs contained the complete extracellular NH
 
2
 
-termi-
nal ectodomains and the transmembrane region (Fig. 4 A).
In addition, we generated nonmembrane-anchored E-cad-
herin fragments, representing either the p120ctn (BD-p120)
or the 
 
 
 
-catenin (BD-
 
 
 
cat) binding domains. Upon tran-
sient transfection, tagged E-cadherin fragments were ex-
pressed at significant levels and demonstrated the expected
molecular weights as shown by immunoblotting of total cell
lysates using anti-myc or anti-GFP antibodies (Fig. 4 B,
asterisks). Unlike the membrane-anchored E-cadherin frag-
ment missing the 
 
 
 
-catenin binding site (Fig. 4 C, c, Ecad-
p120), the 
 
 
 
-catenin–binding E-cadherin fragment (Ecad-
 
 
 
cat) localized to the plasma membrane and led to increased
 
 
 
-catenin levels in both epithelial and fibroblastoid cells and
caused a partial translocation of 
 
 
 
-catenin from the cyto-
 
plasm to the membrane in fibroblastoid cells (Fig. 4 C, a).
The overexpressed cytoplasmic E-cadherin domains, BD-
 
 
 
cat
and BD-p120, were distributed more diffusely throughout
the cytoplasm and nucleus (Fig. 4 C, b and d), and as ex-
pected the 
 
 
 
-catenin fragment (Fig. 4 C, b, BD-
 
 
 
cat) stabi-
lized endogenous 
 
 
 
-catenin.
To test the effects of transiently expressed E-cadherin mu-
tants on cell cycle progression, we determined BrdU incor-
poration 48 h after transfection. In fibroblastoid cells lacking
endogenous E-cadherin, both constructs containing the
 
 
 
-catenin binding site with (Ecad-
 
 cat) or without the
transmembrane domain (BD- cat) clearly reduced the num-
ber of BrdU-positive cells compared with GFP-expressing
cells in a dose-dependent manner (Fig. 5 A, right), whereas
E-cadherin fragments missing the  -catenin binding site
(Ecad-p120; BD-p120) had no significant effect. Further-
more, analysis of  -catenin transcriptional activity using the
Figure 5. Growth-suppressive effect of E-cadherin fragments is 
strictly correlated with downregulation of  -catenin/LEF-1 
transcriptional activity. Epithelial and fibroblastoid FosER cells 
were transfected with expression plasmids for GFP-tagged full-
length E-cadherin, E-cadherin deletion mutants, E-cadherin– -catenin 
chimera, or with GFP alone and analyzed for BrdU incorporation 
(A) and TOPFLASH activity (B) 24 h after transfection. (A) BrdU
incorporation as in Fig. 2, depicting cells with weak (white bar) and 
strong (black bar) expression of ectopic proteins. (B) Cells were 
transfected with LEF-1–dependent TOPFLASH luciferase reporter 
construct together with expression plasmids encoding E-cadherin 
fragments and cytomegalovirus  -galactosidase reporter plasmid. 
Luciferase activities were normalized for  -galactosidase control. 
Mean values and SD of at least three independent experiments are 
shown. (C) Apoptosis in transfected cells was analyzed by micros-
copy.    ,  50%;   , 30–50%;  ,  30%;  ,  1% of 
transfected cells were apoptotic.1190 The Journal of Cell Biology | Volume 154, Number 6, 2001
TOPFLASH luciferase reporter construct (Korinek et al.,
1997) revealed that exclusively the  -catenin–binding
E-cadherin fragments causing cell cycle arrest also signifi-
cantly reduced  -catenin/LEF-1 activity (Fig. 5 B). Thus,
the negative effect of E-cadherin fragments on cell prolifera-
tion is likely mediated by their interference with the signal-
ing function of endogenous  -catenin and is independent of
their function in cell adhesion. To support this hypothesis,
we expressed a chimeric E-cadherin– -catenin protein miss-
ing the  -catenin binding site, which is active in mediating
cell adhesion but does not interfere with  -catenin signaling
in colon carcinoma cells (Fig. 4 A; Gottardi et al., 2001). As
expected, the chimeric protein reduced neither BrdU incor-
poration nor  -catenin activity in fibroblastoid cells.
In epithelial cells containing endogenous E-cadherin–
 -catenin complexes, the effects of E-cadherin fragments
seemed to be more complex, since all E-cadherin fragments,
including those missing the  -catenin binding site, showed a
significant reduction of BrdU incorporation and caused re-
duction in  -catenin transcriptional activity. This can be ex-
plained by the fact that these fragments may interfere with
endogenous adhesion complexes and indirectly affect tran-
scriptional activity of endogenous  -catenin (see Discussion).
Taken together, these experiments showed that the ability
of E-cadherin fragments to arrest cell cycle progression cor-
related strictly with their effects on  -catenin signaling activ-
ity. Furthermore, the ability of E-cadherin fragments to in-
terfere with  -catenin activity correlated nicely with the
induction of apoptosis (Fig. 5 C). This raised the interesting
possibility that  -catenin transcriptional activity may be im-
portant for cell cycle progression.
E-cadherin’s growth-inhibiting activity is counteracted 
by increased  -catenin activity
If   -catenin’s transcriptional activity is essential for cell
proliferation, an artificial increase of  -catenin activity in
E-cadherin–overexpressing cells should release them from
cell cycle arrest. As shown in Fig. 6 A, E-cadherin overexpres-
sion in epithelial FosER cells caused a significant ( 50%) re-
duction of endogenous  -catenin/LEF-1 activity, but coex-
pression of ectopic  -catenin or LEF-1 or TCF-3 rescued or
even increased  -catenin activity compared with the control.
To test whether rescue of  -catenin/LEF activity can also
rescue cell cycle progression, we used a reporter construct
containing multiple E2F binding sites in front of the lu-
ciferase gene, which was shown to be activated during G1-S
phase transition in proliferating cells (Krek et al., 1993). The
ectopic E-cadherin–mediated cell cycle arrest is reflected by a
reduction of E2F-dependent reporter activity to  60% of
the control activity in mock-transfected cells (Fig. 6 B). Co-
Figure 6. Upregulation of  -catenin activity rescues E-cadherin–
mediated growth arrest. Epithelial FosER cells were transfected with 
reporter constructs and with constructs encoding E-cadherin alone 
or together with constructs expressing  -catenin or LEF-1 or TCF-3. 
30 h after transfection, cells were lysed and analysed for  -catenin/
LEF-1 reporter gene activity (A) as in Fig. 5 or E2F reporter gene 
activity (B). Graphs show mean relative light units of reporter gene 
activities (plus SD) normalized for  -galactosidase activity from at 
least three independent experiments. Control in B represents activity 
in asynchronously growing cells.
Figure 7.  -Catenin/LEF-1 activity depends on cell proliferation. 
(A) Epithelial and fibroblastoid FosER cells were transfected with 
TOPFLASH or FOPFLASH luciferase and  -galactosidase reporter 
constructs at different cell densities and analyzed after 30 h. (B) 
FosER cells were transfected with reporter constructs and starved for 
48 h in medium without FCS and restimulated for 24 h in complete 
medium before analysis. Data obtained were normalized for 
 -galactosidase activity, and mean values of normalized TOP-
FLASH minus FOPFLASH activities of at least three independent 
experiments (and SD) are shown.E-cadherin and  -catenin control proliferation | Stockinger et al. 1191
expression of  -catenin or LEF-1 or TCF-3 together with
E-cadherin rescued E2F-dependent transcription to values
close to the control or approximately twofold higher levels
than the control. Thus, an increase in  -catenin–dependent
transcriptional activity can overcome E-cadherin–mediated
cell cycle arrest. This conclusion was further supported by
the observation that coexpression of  -catenin with E-cad-
herin–GFP partially rescued the steep decrease in the num-
ber of GFP-positive cells seen in E-cadherin–GFP–express-
ing cells within 4 d of cultivation after transfection (Fig. 3 A,
broken line), indicating reduced apoptosis in these cells.
 -Catenin transcriptional activity is upregulated in 
proliferating versus arrested cells
If  -catenin activity is required for cell cycle progression, the
endogenous activity should undergo cell cycle–dependent
changes. First, we analyzed endogenous  -catenin transcrip-
tional activity in subconfluent, proliferating versus dense,
contact-inhibited cultures. When epithelial cells were grown
at low densities ( 40% confluency), they exhibited an in-
creased  -catenin–LEF-1/TCF activity, which was five- to
sevenfold reduced when cells reached a confluency of  80%
(Fig. 7 A). A similar dependence of  -catenin–LEF-1/TCF–
dependent reporter activity on cell confluency was detected
in fibroblastoid cells except that the overall values of  -cate-
nin transcriptional activity were up to tenfold higher than
in epithelial FosER cells. To account for any unspecific
changes in basic transcriptional activity during different cell
cycle stages, all  -catenin/LEF-1 activities were related to re-
spective reporter activities obtained with a control reporter
containing mutated LEF-1 binding sites unable to bind
LEF-1 (FOPFLASH).
Figure 8. Stable expression of 
E-cadherin in fibroblastoid FosER cells 
reduces cell proliferation rate. Fibro-
blastoid FosER cells were stably trans-
fected with a construct expressing myc-
tagged E-cadherin, and three clones 
were selected by hygromycin resistance. 
(A) Confocal immunofluorescence 
images of fibroblastoid cells and stable 
E-cadherin–expressing cells stained with 
antibodies to E-cadherin and  -catenin. 
(B) Cell lysates of stable clones and of 
fibroblastoid and epithelial FosER cells 
as control were analyzed by immuno-
blotting using antibodies to E-cadherin. 
(C) TOPFLASH minus FOPFLASH 
reporter activities were measured as 
described in the legend to Fig. 7. (D) 
Growth curves of fibroblastoid FosER 
cells and stable clones were determined 
by cell counting in a Thoma chamber. 
Cell numbers were plotted as values 
against cultivation time to indicate dou-
bling times. (E) Immunoblot analysis of 
total cell lysates using antibodies to 
cyclin D1 and p27
KIP1. Bar, 10  m.1192 The Journal of Cell Biology | Volume 154, Number 6, 2001
In a second set of experiments, we arrested cell prolifera-
tion by serum starvation of subconfluent epithelial and fi-
broblastoid FosER cells for 48 h and released them from the
cell cycle block for up to 24 h by addition of serum.  -Cate-
nin/LEF-1 activity increased more than twofold upon serum
stimulation (Fig. 7 B), confirming a strict correlation of cell
proliferation and  -catenin signaling.
Stable expression of ectopic E-cadherin reduced cell 
proliferation in fibroblastoid cells
Our data suggest that the relative expression levels of E-cad-
herin versus  -catenin control  -catenin transcriptional ac-
tivity and cell cycle progression. To address this hypothesis
in more detail, we generated fibroblastoid FosER cell clones
stably expressing ectopic E-cadherin. Immunofluorescence
microscopy revealed that stable E-cadherin–expressing cells
reverted to a typical epithelial morphology with a peripheral
localization of ectopic E-cadherin at cell contacts (Fig. 8 A).
Furthermore, endogenous  -catenin was translocated from
the cytoplasm and nucleus in fibroblastoid cells to E-cad-
herin containing cell–cell contacts. Although the expression
levels of ectopic E-cadherin in three independent stable
clones were found to be  50% of the amount of endoge-
nous E-cadherin in epithelial cells (Fig. 8 B),  -catenin ac-
tivity was reduced up to fivefold in E-cadherin–expressing
clones versus fibroblastoid cells (Fig. 8 C). The analysis of
cell proliferation rates (Fig. 8 D) indicated that the three in-
dependent E-cadherin–expressing fibroblastoid cell clones
grew significantly slower than the E-cadherin–deficient pa-
rental fibroblastoid cells, exhibiting generation times of
20.5, 21.2, and 22.9 h versus 16.2 h. Growth retardation
may be mediated by a decrease in protein (Fig. 8 E) and
mRNA (unpublished data) levels of the positive cell cycle
regulator cyclin D1, whose transcription may be directly
controlled by  -catenin (Tetsu and McCormick, 1999), and
the upregulation of a negative cell cycle regulator, the cdk
inhibitor p27
KIP1 (St. Croix et al., 1998) (Fig. 8 E). E-cad-
herin did not increase apoptosis in these clones (unpublished
data). The reduction in growth rates upon ectopic expres-
sion of E-cadherin in fibroblastoid cells is consistent with
the role of  -catenin signaling in cell proliferation and its
negative control by E-cadherin.
Discussion
The studies presented here revealed novel aspects on the
function and interaction of the well-studied proteins E-cad-
herin and  -catenin. Our data suggest that  -catenin/LEF-1
transcriptional activity, which has been implicated previ-
ously in inducing hyperproliferation in various tumors
(Barker and Clevers, 2000), also plays a role in controlled
cell proliferation in nontransformed cultured mammary epi-
thelial cells and is regulated by physiological stimuli such as
contact inhibition or withdrawal of serum growth factors.
Also, we found that E-cadherin downregulated  -catenin/
LEF activity and negatively affected cell proliferation in a
cell adhesion-independent manner. In previous studies, E-cad-
herin has been implicated in contact inhibition-induced cell
growth arrest in epithelial cells (St. Croix et al., 1998),
which is dependent on cell adhesion. Only very recently was
a similar cell adhesion-independent effect of E-cadherin on
cell proliferation described in SW 480 colon carcinoma cells
(Gottardi et al., 2001). These findings have major implica-
tions for E-cadherin’s role in carcinogenesis. Loss of E-cad-
herin expression seen in many tumors of epithelial origin
(Christofori and Semb, 1999) may have a dual effect, that is,
loss of cell adhesion favoring motility and invasion and in-
duction of cell proliferation by upregulation of  -catenin/
LEF activity.
Is  -catenin activity essential for cell proliferation?
 -catenin–LEF/TCF signaling has been demonstrated pre-
viously to drive cell proliferation during tumor formation by
turning on the expression of c-myc (He et al., 1998) and the
cell cycle regulator cyclin D1 (Shtutman et al., 1999; Tetsu
and McCormick, 1999), whose expression is also regulated
in the cell system used in this study. In addition to various
tumor models in transgenic mice, where  -catenin/LEF/
TCF activity is upregulated in specific tissues (Gat et al.,
1998; Harada et al., 1999; Roose et al., 1999) overexpres-
sion of  -catenin in cultured epithelial cells (Kolligs et al.,
1999; Orford et al., 1999) or the expression of chimeras of
LEF-1 fused to VP16-transactivating domain in chicken
embryo fibroblasts (Aoki et al., 1999) was found to induce
cell proliferation and neoplastic transformation.
Our data that  -catenin activity is increased in proliferat-
ing versus arrested cells and that an increase in  -catenin ac-
tivity can overcome a cell cycle arrest indicate that regulation
of  -catenin activity may be a more general mechanism con-
trolling cell proliferation in mammary epithelial cells, not
necessarily correlated with neoplastic transformation. This
hypothesis is supported by the finding that TCF-4
 /  mice
exhibited a defect in the proliferation of epithelial precursors
in the colon (Korinek et al., 1998). On the other hand,
elimination of  -catenin by gene knockout in mice resulted
in embryonic lethality due to an inability to form dorsal
structures (Huelsken et al., 2000). These defects reflect the
importance of  -catenin in wnt-mediated axis formation,
but cell proliferation did not seem to be affected at this stage
of development. There are two possible explanations for this
observation. First,  -catenin–LEF/TCF–mediated cell pro-
liferation might become important only at later stages of de-
velopment when differentiated cells have to proliferate dur-
ing homeostasis and reorganization of tissues such as in
mammary gland or colon epithelia. Second, plakoglobin,
which is upregulated in  -catenin–deficient cells and com-
pensates for the adhesive role of  -catenin in cell junctions
(Haegel et al., 1995; Huelsken et al., 2000), might also com-
pensate for  -catenin’s role in cell proliferation. Although
plakoglobin only inefficiently forms a complex with LEF/
TCF and DNA (Zhurinsky et al., 2000a), plakoglobin-
dependent transcriptional activity may be favored in the
absence of  -catenin. Interestingly, plakoglobin was found
to possess transforming activity, which was dependent on
LEF/TCF function and unlike  -catenin strongly activated
c-Myc expression in a rat kidney epithelial cell line (Kolligs
et al., 2000).
In any case, other signaling molecules or pathways are
likely to cooperate with  -catenin to induce cell prolifera-
tion in different cell types. Since expression of wnt but notE-cadherin and  -catenin control proliferation | Stockinger et al. 1193
the expression of  -catenin in immortalized Rat-1 fibro-
blasts caused a proliferative response (Young et al., 1998),
additional   -catenin–independent wnt-mediated pathways
may be important.
Molecular mechanism of E-cadherin–mediated cell 
cycle control
Our studies demonstrate that E-cadherin can inhibit cell cy-
cle progression and link its growth suppressive effect to the
downregulation of  -catenin activity. E-cadherin’s prolifera-
tion-inhibiting effect has been described in several previous
studies in vivo and in vitro (Watabe et al., 1994; Miyaki et
al., 1995; Kandikonda et al., 1996; Takahashi and Suzuki,
1996; St. Croix et al., 1998), but the molecular mechanisms
of this phenomenon remained mostly elusive.
We show that E-cadherin’s growth-repressive effect is
clearly dependent on its ability to downregulate  -catenin
activity and that this effect is not dependent on the cell ad-
hesion function of E-cadherin. The latter conclusion is
based on our findings that cell adhesion inactive E-cadherin
fragments, such as the cytoplasmic  -catenin binding do-
main, clearly reduced  -catenin activity and cell growth,
whereas an E-cadherin– -catenin chimera, which mediates
strong cell adhesion but has no effect on  -catenin activity
in fibroblastoid cells (Gottardi et al., 2001), did not affect
cell proliferation.
Although E-cadherin’s cell adhesion activity is not required
for cell cycle regulation, it might contribute to this process
based on the following observations. First, subconfluent, pro-
liferating and dense, contact-inhibited epithelial cells express
similar E-cadherin levels but exhibit different  -catenin–
LEF/TCF activities. We speculate that the formation of
E-cadherin–mediated cell contacts in dense cultures may sta-
bilize E-cadherin–catenin complexes (Adams et al., 1998) and
thereby may reduce the free cytoplasmic pool of  -catenin
available for transcriptional activity. This mechanism might
cooperate with an E-cadherin– and cell adhesion-independent
mechanism, controlling  -catenin activity and allowing a
tight control of cell proliferation. In contrast, fibroblastoid
FosER cells lacking E-cadherin can only activate E-cadherin–
independent pathways, and  -catenin–dependent cell prolif-
eration is less tightly controlled reflected by an overall tenfold
higher  -catenin activity than in epithelial cells and the ability
of cells to grow in multilayers (Eger et al., 2000).
Second, expression of E-cadherin fragments that increase
and/or stabilize cell adhesion in epithelial cells, such as E-cad-
herin fragments containing the p120ctn binding site (see
below) or the E-cadherin– -catenin chimera (Gottardi et
al., 2001), indirectly caused downregulation of  -catenin ac-
tivity and cell cycle arrest by recruiting  -catenin to cell
junctions. Together, these data indicate that  -catenin/
LEF–dependent cell proliferation is controlled by a finely
tuned balance between free E-cadherin– -catenin (not en-
gaged in contacts), E-cadherin– -catenin adhesion com-
plexes, and free  -catenin within a narrow expression win-
dow. This balance can be regulated by several means
including the change in protein expression, formation of sta-
ble E-cadherin– -catenin cell junctions, and various other
signaling pathways in different cell types and tissues. In line
with this model, a change in  -catenin activity does not nec-
essarily predict a change in the detectable nuclear localiza-
tion of  -catenin, since low levels of nuclear  -catenin com-
prising a small subfraction of the cellular  -catenin pool are
sufficient for transcriptional activity (Gottardi et al., 2001).
E-cadherin domains required for growth suppression in 
different cell types
If the reduction of  -catenin activity is the predominant
mechanism by which E-cadherin confers growth arrest, one
would expect that ectopic E-cadherin constructs require a
functional   -catenin interaction domain to mediate this
process. In line with this notion, a similar growth-sup-
pressive effect was observed upon ectopic expression of all
 -catenin–binding E-cadherin fragments containing or lack-
ing the transmembrane and extracellular domains. In accor-
dance with the above model, membrane-anchored or cyto-
plasmic E-cadherin domains lacking the  -catenin binding
domain neither mediated downregulation of  -catenin ac-
tivity nor inhibited cell cycle progression in fibroblastoid
FosER cells.
However, interestingly the fragments lacking the  -catenin
binding region showed both downregulation of  -catenin ac-
tivity and growth suppressive effects in epithelial cells. This
effect can be explained by the ability of these E-cadherin mu-
tants to interfere with endogenous E-cadherin– -catenin
complexes. Since the  -catenin binding-deficient E-cadherin
fragments contained the binding site for p120ctn, it might
be argued that their overexpression recruits endogenous
p120ctn from endogenous E-cadherin complexes. Since
p120ctn has been suggested to negatively effect cell adhesion
strength (Ozawa and Kemler, 1998; Aono et al., 1999; for al-
ternative views see Anastasiadis and Reynolds, 2000), deple-
tion of p120ctn from endogenous E-cadherin complexes
may lead to increased cell adhesion, stabilization of cell junc-
tions, and recruitment of  -catenin, resulting in significantly
lower levels of free signaling-competent  -catenin.
E-cadherin’s role during epithelial carcinogenesis
The multiple changes during development of malignant in-
vasive tumors (Hanahan and Weinberg, 2000) include two
major events: the initiation of uncontrolled cell proliferation
and the loss of cell adhesion, allowing the invasion of sur-
rounding tissues (Birchmeier et al., 1996; Christofori and
Semb, 1999). E-cadherin has been viewed as a classical sup-
pressor of invasion because E-cadherin is responsible for sta-
ble cell adhesion in epithelial tissues and inhibits cell migra-
tion (Larue et al., 1996; Gumbiner, 2000). Observations
that E-cadherin can interfere with  -catenin signaling (Sa-
dot et al., 1998; Simcha et al., 1998; Orsulic et al., 1999;
Eger et al., 2000) suggested that loss of E-cadherin during
carcinogenesis affects not only cell adhesion but causes a
switch in gene expression through upregulation of  -cate-
nin–LEF/TCF activity. In line with this hypothesis, the
 -catenin–LEF target genes matrilysin and fibronectin were
found to be upregulated during EMT (Brabletz et al., 1999;
Gradl et al., 1999) and might contribute to cancer progres-
sion. Our findings here suggest that loss of E-cadherin and
concomitant upregulation of  -catenin–LEF signaling dur-
ing carcinogenesis might also contribute to increased cell
proliferation seen in tumors.1194 The Journal of Cell Biology | Volume 154, Number 6, 2001
Materials and methods
Cell culture and FACS
® analysis
Mouse mammary epithelial cells constitutively expressing FosER (Reich-
mann et al., 1992) were cultured on plastic dishes as described (Eger et
al., 2000). For induction of EMT, cells were cultured in complete me-
dium containing 1  M  -estradiol (Sigma-Aldrich; Chemie GmbH) for
2–3 wk.
Cells transiently expressing GFP fusion proteins were analyzed by
FACS
® (FACSCalibur; Becton Dickinson) after trypsinization and suspen-
sion in ice-cold PBS/1% FCS.
Constructs
To add a COOH-terminal myc tag to full-length E-cadherin, the plasmid
pSK UM (provided by I. Fialka, Institute of Molecular Pathology) contain-
ing the complete cDNA of murine E-cadherin was cut at an internal NheI
site and a KpnI site downstream of the stop codon. A PCR fragment con-
taining the internal NheI site of E-cadherin and an external ClaI site instead
of the stop codon and a PCR fragment encoding a 6  myc tag and ClaI/
KpnI sites at its 5  and 3  ends, respectively (derived from pCS2) (Aberle et
al., 1997) were inserted into pSK UM cut with NheI/KpnI. The cDNA en-
coding complete E-cadherin and the 3  myc tag were excised from this
construct via SpeI/StuI and inserted blunt end into pCS2BC6myc cut with
BamHI/StuI or into the GFP tag expression vector pEGFP-N3 (CLONTECH
Laboratories, Inc.) blunt end via EcoRI. E-cadherin/myc cDNA cut with
HindIII/NotI was cloned into pcDNA3.1/hygro (Invitrogen). cDNAs encod-
ing cytoplasmic E-cadherin fragments were generated by PCR using the
following oligonucleotide primers: 5 -CGGGATCCATGGATGAAAACCT-
GAAGGCAGCCGAC-3  and 5 -CCATCGATTGTCGTCCTCGCCACCG-
CCG-3  for BD- cat and 5 -CGGGATCCATGCGGAGGAGAACGGTGGT-
CAAAGAG-3  and 5 -CCATCGATCAATTTCATCAGGATTGGCAGGACG-
3  for BD-p120. PCR products were cloned into pCS2 in front of the 6 
myc tag via external BamHI/ClaI sites. For the E-cadherin constructs lack-
ing the  -catenin (Ecad-p120) or the p120ctn (Ecad- cat) interaction do-
mains, cDNAs encoding NH2-terminal fragments were generated via PCR
using upper primer 5 -CGCGGATAACCAGAACAAAGACC-3  and lower
primers 5 -GCTCTAGACAGAGAGTCGTAAGGGGGTGC-3  and 5 -
GCTCTAGAATAGTAATACACATTGTCCCGGG-3 , respectively, contain-
ing external 3  XbaI sites. The COOH terminal fragments were generated
by PCR using upper primers 5 -GCTCTAGACTGAACGAGTGGGGCA-
ACCGATTC-3  for E-cad120 and 5 -GCTCTAGACACAGGGGCCTG-
GATGCCCGACCGG-3  for Ecad- cat, both containing an external
5 XbaI site, and the lower primer 5 -CCATCGATTGTCGTCCTCGCCAC-
CGCCG-3  containing an external ClaI site instead of the stop codon.
NH2- and COOH-terminal fragments were cloned into pCS2-Ecad in one
step using internal BstEII/ClaI. The connection of 5  and 3  cDNA frag-
ments by XbaI generated two additional amino acids (ser arg) in the
E-cadherin sequence at position 601/602 for processed Ecad- cat and at
position 676/677 for Ecad-p120. For GFP-tagged constructs, the respec-
tive pCS2 constructs were cut with HindIII/StuI and put into pEGFP-N3
blunt end via EcoRI.
The plasmid encoding the E-cadherin– -catenin fusion protein was pro-
vided by B. Gumbiner (Memorial Sloan-Kettering Cancer Center, New
York, NY) (Gottardi et al., 2001). LEF/TCF-dependent reporter constructs
pTOPFLASH or pFOPFLASH, containing the minimal thymidine kinase
(TK) promoter, and the LEF-1 and TCF-3 expression vectors were gifts from
H. Clevers (University Hospital, Utrecht, Netherlands) (Korinek et al.,
1997), and the E2F-dependent reporter construct (Krek et al., 1993) was
provided by Hans Rotheneder (Institute of Medical Biochemistry, Vienna
Biocenter). The  -catenin expression vector (pCS2 mtMMBC 6  myc)
was obtained from R. Kemler (Max Planck Institute for Immunology,
Freiburg, Germany) (Aberle et al., 1997).
Transfections and reporter gene assays
Subconfluent epithelial and fibroblastoid FosER cells in a 60-mm plastic
dish were transfected with 4  g plasmid DNA using calcium phosphate or
lipofectamine (Life Technologies). Cells were cultivated for 24–96 h after
transfection in normal medium before analyses. For stable transfections, fi-
broblastoid cells transfected with pcDNA3.1/hygro containing full-length
myc-tagged E-cadherin were selected in complete medium containing 200
 g/ml hygromycin B.
For reporter gene assays, cells were cotransfected with the luciferase re-
porter construct, the  -galactosidase control reporter plasmid (pAD-
CMV1: gal), and expression plasmids for E-cadherin,  -catenin, LEF-1, or
TCF-3 as described (Eger et al., 2000). Luciferase activity was normalized
to  -galactosidase activity as an internal control for transfection efficiency.
Antibodies and immunofluorescence microscopy
The following immunoreagents were used for immunofluorescence mi-
croscopy and for immunoblot analyses: mouse monoclonal antibodies to
 -catenin, p120ctn, E-cadherin, and p27
KIP1 (Transduction Laboratories),
antiserum to  -catenin (Sigma-Aldrich), and mouse monoclonal and poly-
clonal antibodies to c-Myc (CRL-1729; American Type Culture Collection
and Santa Cruz Biotechnology, Inc.). Secondary antibodies coupled to per-
oxidase or alkaline phosphatase were obtained from Promega or Bio-Rad
Laboratories, secondary antibodies conjugated to Alexa Fluor 488 were
from Molecular Probes, and antibodies coupled to Texas red were from
Accurate Chemical & Scientific Corp. or Jackson ImmunoResearch Labora-
tories.
For immunofluorescence microscopy, cells were fixed with methanol-
acetone, stained with primary and secondary antibodies and 0.1  g/ml
Hoechst dye (Eger et al., 2000). Samples were viewed on a ZEISS Axiovert
100M equipped with a LSM 510 confocal microscope.
For analyses of BrdU incorporation, cells were pulsed with 10  mol/
BrdU for 2 h, rinsed with PBS, and fixed with 70% ethanol/50 mM glycine,
pH 2.0, for 30 min at  20 C before immunostaining (Boehringer).
Promega’s apoptosis detection system was used to identify apoptotic cells.
Other procedures
SDS-PAGE and electrotransfer of proteins was done as described previ-
ously (Eger et al., 2000). For the immunological detection of the proteins,
the Protoblot Immunoscreening system (Promega) or the Super Signal ECL
system (Pierce Chemical Co.) was used.
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